Publications by authors named "Daniel Rycroft"

Claim this Profile
F
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.
Alexander P Simpson, Ali Roghanian, Robert J Oldham, H T Claude Chan, Christine A Penfold, Daniel Rycroft

Cell Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells.
Alexandros Karampatzakis, Petr Brož, Camille Rey, Björn Önfelt, Gabriela Dos Santos Cruz De Matos, Daniel Rycroft

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth.
Heather Jackson, David Granger, Gavin Jones, Louisa Anderson, Sarah Friel, Daniel Rycroft

Mol Cancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.
Laura J Goodall, Milan Ovecka, Daniel Rycroft, Sarah L Friel, Andrew Sanderson

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha.
Daniel Rycroft, Jane Sosabowski, Edward Coulstock, Marie Davies, John Morrey

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for determining the PK parameters of AlbudAbs™ and of long serum half-life drugs made using the AlbudAb™ technology.
Daniel Rycroft, Lucy J Holt

Methods Mol Biol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
Hongzheng Zhang, Sujin Yun, Thil D Batuwangala, Michael Steward, Steve D Holmes, Daniel Rycroft

Int J Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
Selwyn J Hurwitz, Hongzheng Zhang, Sujin Yun, Thil D Batuwangala, Michael Steward, Daniel Rycroft

Cancer Chemother Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon.
Adam Walker, Gráinne Dunlevy, Daniel Rycroft, Peter Topley, Lucy J Holt

Protein Eng Des Sel· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis